These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cerebrospinal fluid corticotropin-releasing factor levels and stimulation test in dementia of the Alzheimer type. Martignoni E; Petraglia F; Costa A; Monzani A; Genazzani AR; Nappi G J Clin Lab Anal; 1990; 4(1):5-8. PubMed ID: 2313466 [TBL] [Abstract][Full Text] [Related]
24. Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls. Chappell P; Leckman J; Goodman W; Bissette G; Pauls D; Anderson G; Riddle M; Scahill L; McDougle C; Cohen D Biol Psychiatry; 1996 May; 39(9):776-83. PubMed ID: 8731518 [TBL] [Abstract][Full Text] [Related]
25. Spinal fluid evacuation may provide temporary relief for patients with unexplained widespread pain and fibromyalgia. Hulens M; Rasschaert R; Dankaerts W; Stalmans I; Vansant G; Bruyninckx F Med Hypotheses; 2018 Sep; 118():55-58. PubMed ID: 30037615 [TBL] [Abstract][Full Text] [Related]
26. Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome. Kop WJ; Lyden A; Berlin AA; Ambrose K; Olsen C; Gracely RH; Williams DA; Clauw DJ Arthritis Rheum; 2005 Jan; 52(1):296-303. PubMed ID: 15641057 [TBL] [Abstract][Full Text] [Related]
27. Salivary cortisol release and hypothalamic pituitary adrenal axis feedback sensitivity in fibromyalgia is associated with depression but not with pain. Wingenfeld K; Nutzinger D; Kauth J; Hellhammer DH; Lautenbacher S J Pain; 2010 Nov; 11(11):1195-202. PubMed ID: 20627822 [TBL] [Abstract][Full Text] [Related]
29. Function of the hypothalamic adrenal axis in patients with fibromyalgia syndrome undergoing mud-pack treatment. Bellometti S; Galzigna L Int J Clin Pharmacol Res; 1999; 19(1):27-33. PubMed ID: 10450540 [TBL] [Abstract][Full Text] [Related]
30. Bone turnover and hormonal perturbations in patients with fibromyalgia. El Maghraoui A; Tellal S; Achemlal L; Nouijai A; Ghazi M; Mounach A; Bezza A; Derouiche el M Clin Exp Rheumatol; 2006; 24(4):428-31. PubMed ID: 16956434 [TBL] [Abstract][Full Text] [Related]
31. Pathophysiology and antioxidant status of patients with fibromyalgia. Iqbal R; Mughal MS; Arshad N; Arshad M Rheumatol Int; 2011 Feb; 31(2):149-52. PubMed ID: 20376669 [TBL] [Abstract][Full Text] [Related]
32. CSF corticotropin-releasing factor in personality disorder: relationship with self-reported parental care. Lee RJ; Gollan J; Kasckow J; Geracioti T; Coccaro EF Neuropsychopharmacology; 2006 Oct; 31(10):2289-95. PubMed ID: 16880775 [TBL] [Abstract][Full Text] [Related]
33. Stress exacerbates pain in the everyday lives of women with fibromyalgia syndrome--The role of cortisol and alpha-amylase. Fischer S; Doerr JM; Strahler J; Mewes R; Thieme K; Nater UM Psychoneuroendocrinology; 2016 Jan; 63():68-77. PubMed ID: 26431802 [TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid concentrations of biogenic amines and corticotropin-releasing factor in adolescent non-human primates as a function of the timing of adverse early rearing. Mathew SJ; Coplan JD; Smith EL; Scharf BA; Owens MJ; Nemeroff CB; Mann JJ; Gorman JM; Rosenblum LA Stress; 2002 Sep; 5(3):185-93. PubMed ID: 12186681 [TBL] [Abstract][Full Text] [Related]
35. Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Geisser ME; Strader Donnell C; Petzke F; Gracely RH; Clauw DJ; Williams DA Psychosomatics; 2008; 49(3):235-42. PubMed ID: 18448779 [TBL] [Abstract][Full Text] [Related]
36. Pain, psychological variables, sleep quality, and natural killer cell activity in midlife women with and without fibromyalgia. Landis CA; Lentz MJ; Tsuji J; Buchwald D; Shaver JL Brain Behav Immun; 2004 Jul; 18(4):304-13. PubMed ID: 15157947 [TBL] [Abstract][Full Text] [Related]
37. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Tanriverdi F; Karaca Z; Unluhizarci K; Kelestimur F Stress; 2007 Mar; 10(1):13-25. PubMed ID: 17454963 [TBL] [Abstract][Full Text] [Related]
38. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine. Bonne O; Gill JM; Luckenbaugh DA; Collins C; Owens MJ; Alesci S; Neumeister A; Yuan P; Kinkead B; Manji HK; Charney DS; Vythilingam M J Clin Psychiatry; 2011 Aug; 72(8):1124-8. PubMed ID: 21208596 [TBL] [Abstract][Full Text] [Related]
39. Childhood maltreatment and diurnal cortisol patterns in women with chronic pain. Nicolson NA; Davis MC; Kruszewski D; Zautra AJ Psychosom Med; 2010 Jun; 72(5):471-80. PubMed ID: 20467005 [TBL] [Abstract][Full Text] [Related]
40. Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders. Tomori N; Suda T; Tozawa F; Demura H; Shizume K; Mouri T J Clin Endocrinol Metab; 1983 Dec; 57(6):1305-7. PubMed ID: 6605358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]